Nobert Höfgen

Title: Nobert Höfgen: Innovator in Therapeutic Agents

Introduction

Nobert Höfgen is a notable inventor based in Ottendorf-Okrilla, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 2 patents, his work focuses on innovative compounds that have the potential to treat various disorders.

Latest Patents

Höfgen's latest patents include the invention of substituted 7-azaindoles and their use as therapeutic agents. This invention relates to a process for the preparation of these compounds, which serve as inhibitors of phosphodiesterase 4. These compounds are particularly effective in treating disorders influenced by the inhibition of phosphodiesterase 4 activity in immunocompetent cells, such as macrophages and lymphocytes. Another significant patent involves substituted 4-, 6-, or 7-hydroxyindoles with N-oxide groups, which also act as inhibitors of phosphodiesterase 4 and are used in pharmaceutical preparations for similar therapeutic applications.

Career Highlights

Höfgen is currently associated with Elbion AG, a company that focuses on the development of innovative pharmaceutical solutions. His work at Elbion AG has been instrumental in advancing the understanding and application of phosphodiesterase inhibitors in medical treatments.

Collaborations

Some of his notable coworkers include Hildegard Kuss and Karin Steinike, who have collaborated with him on various projects within the pharmaceutical domain.

Conclusion

Nobert Höfgen's contributions to the field of therapeutic agents highlight his innovative spirit and dedication to improving healthcare through scientific advancements. His patents reflect a commitment to developing effective treatments for disorders that impact immunocompetent cells.